Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Dec 10, 2024. (Total: 234259Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 9 (of 9 Records)

Query Trace: Overdose and VKORC1[original query]
Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity.
Blood 2005 Jul 106 (1): 135-40.
Bodin Laurent, Verstuyft Céline, Tregouet David-Alexandre, Robert Annie, Dubert Liliane, Funck-Brentano Christian, Jaillon Patrice, Beaune Philippe, Laurent-Puig Pierre, Becquemont Laurent, Loriot Marie-An
[The c.-1639g > A polymorphism of the VKORC1 gene and his influence on the therapeutic response during oral anticoagulants use].
Vojnosanitetski pregled 2009 Aug 66 (8): 617-21.
Kovac Mirjana, Raki?evi? Ljiljana, Masla? Aleksandar, Radojkovi? Dragi
The c.-1639G>A polymorphism of the VKORC1 gene in Serbian population: retrospective study of the variability in response to oral anticoagulant therapy.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2010 Sep 21 (6): 558-63.
Kovac Mirjana K, Maslac Aleksandar R, Rakicevic Ljiljana B, Radojkovic Dragica
Frequency of selected single nucleotide polymorphisms influencing the warfarin pharmacogenetics in Slovak population.
European journal of haematology 2014 Oct 93 (4): 320-8.
Kraj?íová L'ubica, Petrovi? Robert, Déžiová L'udmila, Chandoga Ján, Tur?áni Pet
Frequencies of polymorphisms in CYP2C9 and VKORC1 genes influencing warfarin metabolism in Slovak population: implication for clinical practice.
Bratislavské lekárske listy 2014 115 (9): 563-8.
Krajciova L, Deziova L, Petrovic R, Luha J, Turcani P, Chandoga
VKORC1 polymorphisms and warfarin maintenance dose in population of Sakha (Yakuts).
The International journal of risk & safety in medicine 2015 Nov 27 Suppl 1 S17-8.
Chertovskikh Y V, Malova E U, Maksimova N R, Popova N V, Sychev D
CYP2C9 and VKORC1 in therapeutic dosing and safety of acenocoumarol treatment: implication for clinical practice in Hungary.
Environmental toxicology and pharmacology 2017 Oct 56 282-289.
Varnai Reka, Sipeky Csilla, Nagy Lajos, Balogh Sandor, Melegh Be
Frequency of vitamin K oxidoreductase complex subunit-1 (VKORC1) polymorphisms and warfarin dose management in patients with venous thromboembolism.
The pharmacogenomics journal 2018 Aug .
Kabalak P?nar Ak?n, Sava? ?smail, Akar Nejat, Demir Nalan, E?in Yon
Correlation between CYP2C9 gene polymorphism and warfarin dose in Chinese Han population with coronary heart disease.
Cellular and molecular biology (Noisy-le-Grand, France) 2021 Dec 67 (5): 157-163.
Zuo Qiyu, Li Li, Zhong Mingjing, Chen Gengbiao, Xio Junh
TOP